MicroVision is this report's most direct, real-time case study of the LiDAR industry's consolidation wave described in §9 of the primer — and a cautionary one. On 3 February 2026, it closed the acquisition of substantially all of Luminar Technologies' lidar business (the Iris long-range and Halo short-range product lines, related IP and inventory, key engineering staff, and roughly 30 customer engagements) out of a Chapter 11 bankruptcy auction, for $33.0 million cash. Luminar's collapse was triggered by Volvo formally terminating its EX90/ES90 lidar contract on 14 November 2025 — the industry's most prominent automotive design win, gone — and Luminar was delisted from Nasdaq (Form 25 filed 23 January 2026, effective 2 February 2026) the day before the MicroVision deal closed. This report's research found no evidence that Luminar's other marquee relationships (a "multibillion dollar" Mercedes-Benz agreement, Feb 2023, and a Polestar relationship) ever converted to production business either. What MicroVision actually acquired, on its own disclosure, is IP, inventory, engineering talent and a generic set of ~30 smaller customer engagements — not a confirmed transfer of Luminar's headline OEM contracts. Readers should not assume Volvo, Mercedes-Benz or Polestar are MicroVision customers today; no source found in this research confirms that any of them are.
MicroVision now runs four distinct lidar technology lines simultaneously — its own MEMS-based MOVIA (built with Tier-1 partner ZF), the acquired Iris/Halo time-of-flight lines, and Scantinel's FMCW technology (acquired January 2026, a ~20-person Ulm, Germany team) — under a "Lidar 2.0" strategy positioning it as a multi-architecture, multi-market (automotive, industrial, defense) consolidator. Combined with the earlier 2023 Ibeo acquisition, this is now three separate M&A integrations inside three years, alongside a workforce reduction (reported at ~15-20%) and a headquarters consolidation from Redmond, WA into Orlando, FL — Luminar's former home. Management describes a >100-opportunity, ~$500 million booking pipeline across its combined markets; this is a company-disclosed opportunity estimate, not booked or contracted revenue.
The financial reality behind this strategy is severe. Q2 2026 revenue was just $1.473 million (including only $0.9 million from the newly-acquired Luminar business) against a net loss of $36.9 million — and MicroVision's own Q2 2026 10-Q states explicitly that "the combination of the higher cash burn during the first half of 2026 with historical losses and current liquidity... raises substantial doubt about the Company's ability to continue as a going concern through at least twelve months." Cash was $27.2 million at 30 June 2026 against six-month operating cash burn of $35.6 million — a run-rate that, unaddressed, exhausts the current cash position in well under two quarters. A 1-for-15 reverse stock split (effective 1 August 2026) restored Nasdaq minimum-bid-price compliance (confirmed 26 August 2026), but MicroVision has now received bid-price deficiency notices in 2011, 2019-2020 and 2026 — a structurally recurring pattern, not a one-off.
Net: SELL. MicroVision is simultaneously the industry's most literal consolidator — three acquisitions in three years, four sensor architectures under one roof — and its own balance sheet carries the single most severe, explicitly disclosed going-concern warning in this report's coverage universe. "Consolidation" in this industry, this company shows plainly, is happening among financially strained survivors, not necessarily strong ones.
MicroVision is a Nasdaq-listed, SEC-reporting US domestic issuer subject to the full 10-K/10-Q disclosure regime, not a foreign private issuer. Its FY2025 10-K was audited by Baker Tilly US, LLP (report dated 4 March 2026). The company is also subject to a specific liquidity covenant tied to its February 2026 convertible notes, requiring it to maintain minimum cash of the lesser of $17.5 million or 110% of the outstanding convertible-note balance — a contractual, not just disclosure-based, constraint on top of ordinary SEC reporting obligations.
The going-concern language is disclosed plainly and explicitly in the 10-Q rather than buried or omitted — exactly the kind of direct disclosure this report's own methodology rewards, even when the underlying news is bad. Leadership changes (CEO September 2025, CFO and Chief Commercial Officer September 2026) were announced with standard SEC 8-K disclosure and RSU inducement-grant detail. The company proactively addressed its Nasdaq compliance risk via a shareholder-approved reverse split rather than waiting for a delisting determination.
One ownership-aggregator source cites a 109.2 million-share institutional holding figure that is larger than MicroVision's entire post-split share count (~23.8 million) — almost certainly a pre-split figure not correctly adjusted by the aggregator; this report could not independently re-verify the underlying institutional/insider/retail percentages (~26.1%/9.4%/64.4%) against a primary, post-split source. A related-party financing element also exists at board level: the July 2026-authorized Sylebra Capital standby facility ($125 million, through 8 November 2026) sits alongside board member Christopher Gibson's role as Sylebra's Founder/CIO — a disclosed relationship worth independent scrutiny in the FY2026 annual report's related-party-transaction note (see Aeva's report for the same facility on the other side of the arrangement).
No adjudicated misconduct was identified, but the going-concern warning is itself the most serious disclosed financial red flag in this report's entire coverage universe — a formal, explicit statement of substantial doubt about the company's ability to continue operating, not a softer analyst concern. A 2020-era plaintiffs'-firm litigation-investigation notice (Bronstein, Gewirtz & Grossman) was found but could not be confirmed as having resulted in an actual filed, currently active lawsuit — flagged as stale/unresolved rather than an active matter.
Whether the going-concern qualification is resolved, worsened, or reiterated in the next 10-Q; whether any named automotive OEM customer is disclosed as having transferred from the Luminar acquisition; resolution of the pre-/post-split ownership-data discrepancy; and the pace of ATM/shelf usage against the disclosed $41.2 million remaining availability.
Disclosure is honest; the underlying financial position is genuinely precarious. MicroVision has not hidden its going-concern risk — it has stated it in the plainest possible regulatory language — and that candour is itself a governance positive. But candid disclosure of a severe problem does not make the problem smaller: this report's SELL rating reflects the disclosed facts, not a governance-quality discount layered on top of them.
Standard revenue or earnings multiples are not meaningful for MicroVision given its explicit going-concern status and a revenue base ($1.473mn, Q2 2026) too small relative to its $36.9mn quarterly net loss to support any conventional multiple. We instead anchor this valuation on disclosed book value per share — total stockholders' equity of $20.619mn ÷ 23.79mn shares outstanding (both 30 June 2026) = **$0.867 book value/share** — and apply scenario multiples that explicitly price the going-concern risk, rather than assuming a "no change" base case:
| Scenario | Price/Book multiple | Book value/share ($) | Target price | Upside/(downside) |
|---|---|---|---|---|
| Bear — near-term insolvency/rescue-financing risk materialises | 0.3x | 0.867 | 0.26 | (84.5)% |
| Base — going concern persists, heavily discounted | 0.6x | 0.867 | 0.52 | (69.0)% |
| Bull — successful recapitalisation and pipeline conversion | 2.5x | 0.867 | 2.17 | +29.2% |
Base case rounded to $0.52. Note that even the bull-case scenario requires a genuinely favourable resolution of the going-concern matter and real conversion of the disclosed pipeline — it is not this report's central expectation. Source: MicroVision Q2 2026 Form 10-Q (SEC EDGAR), stockanalysis.com market data (22 Sep 2026).
Upgrade triggers: the going-concern qualification being formally lifted in a subsequent 10-Q; a confirmed, named, material customer contract disclosed for the acquired Luminar business; a non-dilutive or minimally dilutive financing resolving the liquidity covenant risk. Downgrade triggers: the going-concern language being reiterated or strengthened; a further, highly dilutive emergency raise; a fourth Nasdaq bid-price deficiency notice.
| FY2025 | Q2 2025 | Q2 2026 | |
|---|---|---|---|
| Revenue ($mn) | 1.208 | 0.155 | 1.473 |
| Gross margin | NM (gross loss) | — | 43.6% |
| Net loss ($mn) | (94.981) | (14.2) | (36.9) |
| Selected metrics | Latest |
|---|---|
| Cash and cash equivalents (30 Jun 2026) | $27.2mn |
| H1 2026 operating cash burn | $35.6mn |
| Total stockholders' equity (30 Jun 2026) | $20.619mn |
| Luminar acquisition price | $33.0mn cash |
| ATM facility remaining availability | ~$41.2mn |
Source: MicroVision FY2025 Form 10-K (filed 4 Mar 2026) and Q2 2026 Form 10-Q (SEC EDGAR), MicroVision investor-relations press releases, stockanalysis.com (22 Sep 2026). All figures split-adjusted for the August 2026 1-for-15 reverse stock split unless otherwise noted.
Dart Consultants is a market intelligence and technology service provider, not a SEC-registered Investment Adviser or FINRA-registered Broker-Dealer. This report is educational material only — not investment advice, and not a recommendation to buy or sell any stock. The SELL rating above is an educational device for summarising public information, not a regulated recommendation. The analyst(s) hold no position in, and have no banking, advisory or brokerage relationship with, MicroVision, Inc., and have received no compensation from the company.
| 12-month target | $0.52 |
| CMP (22 Sep 2026) | $1.68 |
| Implied downside | (69.0)% |
| Rating | SELL |
| Market cap | $40.92mn |
| P/E (trailing) | NM — net loss |
| 52-week range | $1.412–$23.10* |
| Debt/Equity | ~1.19x (notes only) |
| Going concern | Explicit, disclosed |
| Institutional | ~26.1%† |
| Insiders | ~9.4%† |
| Retail | ~64.4%† |
| Q2 25 | Q2 26 | |
|---|---|---|
| Revenue | 0.155 | 1.473 |
| Net loss | (14.2) | (36.9) |
*Split-adjusted for the Aug 2026 1-for-15 reverse split. †Source share count appears pre-split; treat as approximate — see Governance.
